Gilead Sciences Inc. Feedback

Risk

GrahamNumber 41.14 60.65
RD Expense Growth 226.61% <30%
Debt/Equity 1.74 <3

Growth

Revenue Growth mean (3y) 2.58% >10%
Gross Profit Growth mean (3y) 2.72% >10%
EPS Growth mean (3y) 21998.86% >10%
Operating CF Growth (3y) 66.82% >10%

Prospects

EPS mean (3y) 1.42 >10
ROE 23.91% >20%
PE 14.83 <12
PEG 3.45 <1.5, ideal 1

Rating

Rating Score 5 =5

StockVoter's opinion (30 days prognosis)


Your vote